Denali Therapeutics Inc
DNLILatest QuantConomy context for DNLI: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Denali Therapeutics Inc
QuantConomy has a structured record for DNLI. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- DNLI
- Name
- Denali Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for DNLI
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Feb 26, 12:00 AM | DNLI filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-26. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| material agreement | bullish | 85 | Jun 18, 01:10 PM | DNLI filed 8-K: Material Definitive Agreement, Regulation FD Disclosure - 2 material events - [very strong bullish signal] |
| other event | neutral | 35 | Jun 4, 10:05 AM | DNLI filed 8-K: Shareholder Vote Results - [weak neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| DNLI | NASDAQ | fmp | Denali Therapeutics Inc. |
| DNLI | NASDAQ | alphavantage | Denali Therapeutics Inc |
| DNLI | NASDAQ | alpaca | Denali Therapeutics Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Van Hauwermeiren Timothy | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP | Director | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | Krognes Steve E. | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | Klein Peter S | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | Schenkein David P | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | Cook Jennifer E. | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | FLATLEY JAY T | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | Thornberry Nancy | Insider | grant | 6,408 | $0.00 | $0 | 4 on EDGAR |
| — | Chin Peter Scott | Chief Medical Officer | — | — | — | — | 3 on EDGAR |
| — | Chin Peter Scott | Chief Medical Officer | — | — | — | — | 3 on EDGAR |
| Jan 6, 2026 | Schuth Alexander O. | COFO and Secretary | sale | 17,218 | $16.50 | $284,097 | 4 on EDGAR |
| Jan 6, 2026 | Watts Ryan J. | President and CEO | sale | 35,198 | $16.50 | $580,767 | 4 on EDGAR |
| Jan 3, 2026 | Schuth Alexander O. | COFO and Secretary | grant | 57,700 | $0.00 | $0 | 4 on EDGAR |
| Jan 3, 2026 | Watts Ryan J. | President and CEO | grant | 78,960 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Insider | purchase | 190,523 | $17.49 | $3,332,247 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query DNLI context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access